Search Results for citation:"86 FR 8213"

Found 3 results

Search Results: citation:"86 FR 8213"

💰 Only
Oldest Newest
  • 2021-02275 — National Institute of Allergy and Infectious Diseases; Notice of Closed Meeting
    Type:Notice
    Citation:86 FR 8213
    Reading Time:about a minute or two

    The National Institute of Allergy and Infectious Diseases (NIAID) will hold a special meeting on February 23, 2021, to review and evaluate grant applications. This meeting will be conducted virtually and is closed to the public to protect confidential information related to trade secrets and personal privacy. Zhuqing (Charlie) Li, Ph.D., will serve as the Scientific Review Officer for this session. The meeting agenda will focus solely on research projects that do not involve clinical trials.

    Simple Explanation

    The National Institute of Allergy and Infectious Diseases is having a secret online meeting on February 23, 2021, to talk about research projects and decide who gets money to study things. They are keeping the meeting private to protect important secrets and people’s privacy.

  • 2021-02274 — National Center for Advancing Translational Sciences; Notice of Closed Meeting
    Type:Notice
    Citation:86 FR 8213
    Reading Time:about a minute or two

    The National Center for Advancing Translational Sciences, part of the National Institutes of Health, announced a closed meeting for February 18, 2021. The meeting, taking place virtually, will review and evaluate grant applications related to rare diseases. It is closed to the public to protect confidential information, trade secrets, and private details of individuals connected to the applications. Contact details for Dr. Carol Lambert at the Office of Scientific Review are provided for further inquiries.

    Simple Explanation

    The National Center for Advancing Translational Sciences is having a private online meeting on February 18, 2021, to talk about special projects to help people with rare diseases, and it's private because they're discussing secret things. If anyone wants to know more, they can ask Dr. Carol Lambert at the office.

  • 2021-02294 — Government-Owned Inventions; Availability for Licensing
    Type:Notice
    Citation:86 FR 8213
    Reading Time:about 2 minutes

    The National Institutes of Health (NIH) is offering a government-owned invention for licensing. This invention is a vaccine that uses a virus vector called VSV-EBOV to express the spike protein of the SARS-CoV-2 virus, which causes COVID-19. The vaccine has shown effective protection against the virus in animal tests, and it only requires a single dose. It is designed to be inexpensive to produce and provides high levels of antibodies to fight COVID-19.

    Simple Explanation

    The government has a special invention that can help protect people from a virus called COVID-19. They're looking for companies to make and sell the vaccine so it can help lots of people stay healthy.